Literature DB >> 16611054

Intracellular restriction factors in mammalian cells--An ancient defense system finds a modern foe.

Jörg G Baumann1.   

Abstract

Cross-species transmission of retroviruses poses a threat to mammalian species. Zoonoses have given rise to devastating diseases because the host organism is not prepared to resist a new pathogen. Mammals have developed several layers of defense against viruses, including an intracellular antiretroviral defense, a part of innate immunity. Retroviral restrictions had been studied for decades using murine leukemia virus in mice, however it has become clear that primates too have intrinsic mechanisms to ward off infections by retroviruses. Several of these antiretroviral restriction mechanisms have recently been identified, with two particularly well described factors being members of the tripartite motif (Trim) and APOBEC families. Both systems provide a strong barrier against lentiviral infections. The viruses have developed countermeasures that allow them to replicate despite the host factors. This review discusses our current knowledge of this ancient battle between mammalian hosts and their retroviral opponents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611054     DOI: 10.2174/157016206776055093

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  12 in total

Review 1.  Host factors that control long terminal repeat retrotransposons in Saccharomyces cerevisiae: implications for regulation of mammalian retroviruses.

Authors:  Patrick H Maxwell; M Joan Curcio
Journal:  Eukaryot Cell       Date:  2007-05-11

Review 2.  Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution?

Authors:  Frank Kirchhoff
Journal:  Nat Rev Microbiol       Date:  2009-03-23       Impact factor: 60.633

3.  Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors.

Authors:  Richard A Voit; Moira A McMahon; Sara L Sawyer; Matthew H Porteus
Journal:  Mol Ther       Date:  2013-01-29       Impact factor: 11.454

4.  Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.

Authors:  Baoming Liu; Nan L Li; Jie Wang; Pei-Yong Shi; Tianyi Wang; Mark A Miller; Kui Li
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

5.  Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection.

Authors:  Shamman Sewram; Ravesh Singh; Emil Kormuth; Lise Werner; Koleka Mlisana; S S Abdool Karim; Thumbi Ndung'u
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

6.  The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.

Authors:  Baoming Liu; Nan L Li; Yang Shen; Xiaoyong Bao; Thomas Fabrizio; Husni Elbahesh; Richard J Webby; Kui Li
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 7.  Foamy virus vectors for gene transfer.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

8.  Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Authors:  Bin Jia; Ruth Serra-Moreno; William Neidermyer; Andrew Rahmberg; John Mackey; Ismael Ben Fofana; Welkin E Johnson; Susan Westmoreland; David T Evans
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

Review 9.  NALP inflammasomes: a central role in innate immunity.

Authors:  Fabio Martinon; Olivier Gaide; Virgine Pétrilli; Annick Mayor; Jürg Tschopp
Journal:  Semin Immunopathol       Date:  2007-08-17       Impact factor: 11.759

10.  Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene.

Authors:  Heide Muckenfuss; Julia K Kaiser; Erika Krebil; Marion Battenberg; Christina Schwer; Klaus Cichutek; Carsten Münk; Egbert Flory
Journal:  Nucleic Acids Res       Date:  2007-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.